Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced Myelosuppression

New England Journal of Medicine

Volumn 319, Issue 10, 1988, Pages 593-598

  Antman, Karen S ^a   Griffin, James D ^a   Elias, Anthony ^a   Socinski, Mark A ^a   Ryan, Louise ^a   Cannistra, Stephen A ^a   Oette, Dagmar ^a   Whitley, Mary ^a   Frei, Emil ^a   Schnipper, Lowell E ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACARBAZINE; DOXORUBICIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IFOSFAMIDE; MESNA;

CANCER THERAPY; CLINICAL ARTICLE; DRUG DOSE; HUMAN; LEUKOCYTE COUNT; METASTASIS; NEUTROPHIL; PRIORITY JOURNAL; SARCOMA;

EID: 0023682969     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198809083191001     Document Type: Article

References (26)

1. Frei E III, Canellos GP. Dose: a critical factor in cancer chemotherapy. Am J Med 1980; 69: 585–94.
2. Metcalf D. The granulocytemacrophage colony-stimulating factors. Science 1985; 229: 16–22.
3. Clark SC, Kamen R. The human hematopoietic colony-stimulating factors. Science 1987; 236: 1229–37.
4. Metcalf D. Begley CG, Johnson GR, et al. Biologic properties in vitro of a recombinant human granulocytemacrophage colony-stimulating factor. Blood 1986; 67: 37–45.
5. Tomonaga M, Golde DW, Gasson JC. Biosynthetic (recombinant) human granulocytemacrophage colony-stimulating factor: effects on normal bone marrow and leukemia cell lines. Blood 1986; 67: 31–6.
6. Sieff CA, Emerson SG, Donahue RE, et al. Human recombinant granulocytemacrophage colony-stimulating factor: a multilineage hematopoietin. Science 1985; 230: 1171–3.
7. Gasson JC, Weisbart RH, Kaufman SE, et al. Purified human granulocytemacrophage colony-stimulating factor: direct action on neutrophils. Science 1984; 226: 1339–42.
8. Weisbart RH, Golde DW, Clark SC, Wong GG, Gasson JC. Human granulocyte–macrophage colony-stimulating factor is a neutrophil activator. Nature 1985; 314: 361–3.
9. Fleischmann J, Golde DW, Weisbart RH, Gasson JC. Granulocytemacrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils. Blood 1986; 68: 708–11.
10. Grabstein KH, Urdal DL, Tushinski RJ, et al. Induction of macrophage tumoricidal activity by granulocytemacrophage colony-stimulating factor. Science 1986; 232: 506–8.
11. Vadas M, Nicola NA, Metcalf D. Activation of antibody-dependent cell-mediated cytotoxicity of human neutrophils and eosinophils by separate colony-stimulating factors. J Immunol 1983; 130: 795–9.
12. Wong GG, Witek JS, Temple PA, et al. Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. Science 1985; 228: 810–5.
13. Donahue RE, Wang EA, Stone DK, et al. Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF. Nature 1986; 321: 872–5.
14. Mayer P, Lam C, Obenaus H, Liehl E, Besemer J. Recombinant human GM-CSF induces leukocytosis and activates peripheral blood polymorpho-nuclear neutrophils in nonhuman primates. Blood 1987; 70: 206–13.
15. Nienhuis AW, Donahue RE, Karlsson S, et al. Recombinant human granulocyte–macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model. J Clin Invest 1987; 80: 573–7.
16. Monroy RL, Skelly RR, MacVittie TJ, et al. The effect of recombinant GM-CSF on the recovery of monkeys transplanted with autologous bone marrow. Blood 1987; 70: 1696–9.
17. Groopman JE, Mitsuyasu RT, DeLeo MJ, Oette DH, Golde DW. Effect of recombinant human granulocyte–macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N Engl J Med 1987; 317: 593–8.
18. Griffin JD, Sullivan R, Beveridge RP, Larcom P, Schlossman SF. Induction of proliferation of purified human myeloid progenitor cells: a rapid assay for granulocyte colony-stimulating factors. Blood 1984; 63: 904–11.
19. Lehman EL. Nonparametrics: statistical methods based on ranks. New York: McGraw-Hill, 1975.
20. Arnaout MA, Wang EA, Clark SC, Sieff CA. Human recombinant granulocytemacrophage colony–stimulating factor increases cell-to-cell adhesion and surface expression of adhesion-promoting surface glycoproteins as mature granulocytes. J Clin Invest 1986; 78: 597–601.
21. Morice RC, Blick MB, Ali MK, Gutterman JU. Pulmonary toxicity of recombinant tumor necrosis factor (rTNF). Proc Am Soc Clin Oncol; 1987; 6: 29. abstract.
22. Rosenberg SA. Lotze MT, Muul LM, et al. A progress report on the treatment of 157 patients with advanced cancer using lymphokinc-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 1987; 316: 889–97.
23. Cannistra SA, Rambaldi A, Spriggs DR, Herrmann F, Kufe D, Griffin JD. Human granulocyte–macrophage colony-stimulating factor induces expression of the tumor necrosis factor genes by the U937 cell line and by normal human monocytes. J Clin Invest 1987; 79: 1720–8.
24. Cannistra SA, Socinski MA, Groshek P, et al. In vivo administration of human granulocyte-monocyte colony stimulating factor (GM-CSF) enhances monocyte tumoricidal activity. Proc Am Soc Clin Oncol 1988; 7: 167. abstract.
25. Sacks T, Moldow CF, Craddock PR, Bowers TK, Jacob HS. Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes: an in vitro model of immune vascular damage. J Clin Invest 1978; 61: 1161–7.
26. Elias AD, Ryan L, Aisner J, Animan KH. Doxorubicin, ifosfamide, and DTIC (AID) for advanced untreated sarcomas. Proc Am Soc Clin Oncol 1987; 6: 134. abstract.